As provisions of the Patient Protection and Affordable Care Act (PPACA), Pub. L. No. 111-148, are implemented to expand coverage and improve the quality of health care, it is important for the health care industry to be aware of another provision in PPACA – the Cures Acceleration Network, which will be a valuable tool to fund the development of cutting edge drugs, diagnostics, biologics, and medical devices.
Please see full publication below for more information.